Literature DB >> 8414027

Prevalence, incidence, and characteristics of multiple sclerosis in Westlock County, Alberta, Canada.

S Warren1, K G Warren.   

Abstract

We report a prevalence study of multiple sclerosis (MS) in the town of Westlock and surrounding county of Westlock, in Alberta, Canada. The prevalence rate for clinically definite MS on January 1, 1991, was 200/100,000. The average annual incidence rates for patients living in the area at onset were 1.91/100,000 for 1950-1959, 2.85/100,000 for 1960-1969, 3.82/100,000 for 1970-1979, and 7.26/100,000 for 1980-1989. Forty-eight percent of the patients were relapsing-remitting. Sixty percent were still walking without assistance. The female-to-male ratio was 1.4:1. Mean current age was 47, age at onset 30, and duration of illness 18 years. The majority of patients (40%) experienced multiple symptom onset. Forty percent were of single ethnic origin (primarily British); the remainder were predominantly north European combinations. Twenty-four percent of patients reported another MS relative, six first-degree and one second-degree relative.

Entities:  

Mesh:

Year:  1993        PMID: 8414027     DOI: 10.1212/wnl.43.9.1760

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

1.  Multiple sclerosis in Finland: incidence trends and differences in relapsing remitting and primary progressive disease courses.

Authors:  M-L Sumelahti; P J Tienari; M Hakama; J Wikström
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-01       Impact factor: 10.154

2.  Aetiology: Neighbourhood watch.

Authors:  Carolyn Brown
Journal:  Nature       Date:  2016-11-30       Impact factor: 49.962

3.  Geomagnetic disturbances may be environmental risk factor for multiple sclerosis: an ecological study of 111 locations in 24 countries.

Authors:  Seyed Aidin Sajedi; Fahimeh Abdollahi
Journal:  BMC Neurol       Date:  2012-09-24       Impact factor: 2.474

4.  The role of exercise in modifying outcomes for people with multiple sclerosis: a randomized trial.

Authors:  Nancy E Mayo; Mark Bayley; Pierre Duquette; Yves Lapierre; Ross Anderson; Susan Bartlett
Journal:  BMC Neurol       Date:  2013-06-28       Impact factor: 2.474

5.  Systematic literature review and meta-analysis of the prevalence of secondary progressive multiple sclerosis in the USA, Europe, Canada, Australia, and Brazil.

Authors:  Vijayalakshmi Vasanthaprasad; Vivek Khurana; Sreelatha Vadapalle; Jackie Palace; Nicholas Adlard
Journal:  BMC Neurol       Date:  2022-08-17       Impact factor: 2.903

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.